维普期刊资源整合服务平台（V6.5）

139篇 您的检索式：作者名="Franco EL"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	2005—2014年出生队列女性的宫颈癌疾病负担和HPV疫苗接种影响的全球估计显示文摘目前全球大多数国家针对适龄女孩开展的人乳头瘤病毒(HPV)疫苗的免疫规划覆盖率仍远低于全球宫颈癌消除战略中推荐的90%阈值。为推进各地区HPV疫苗接种计划的实施,研究根据GLOBOCAN 2018和联合国发布数据,估计了2005—2014年出生的女性中不接种HPV疫苗情况下宫颈癌的预期发病数,并量化评估了HPV疫苗对改善全球宫颈癌疾病负担的影响。截至2094年,全球范围内2005—2014年出生队列女性预计出现1160万例宫颈癌患者。非洲与亚洲地区的疾病负担最重,约有1013万(87.4%)宫颈癌病例,其后为拉丁美洲,约87万例(7.4%)。	Bonjour M Charvat H Franco EL 张锦雨(编译)	2021	中华医学杂志2021，101，24：	3
2	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial 显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
3	Embracing a new era in cervical cancer screening显示文摘	Isidean SD Franco EL	2014	Lancet2014，383，9916：	1
4	The epidemiology of cervical cancer 显示文摘	Franco EL Schlecht NF Saslow D	2003	Cancer J2003，9，5：	1
5	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
6	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women :a randomised controlled trial 显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
7	Efficacy of a bi- valent L1 virus-like particle vaccine in prevention of in- fection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial 显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
8	The epidemiology of genital human papillomavirus infection显示文摘	Trottier H Franco EL	2006	Vaccine2006，3，：	1
9	Cervical caneer:epidemiology,prevention and the role of HPV infection 显示文摘	FRANCO EL DUARTE-FRANCO E FERENCZY A	2001	CMAJ2001，164，7：	1
10	Management of low-grade cervical lesions in young women显示文摘	Lau S Franco EL		0，，07：	1
11	Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high -risk area for cervical cancer 显示文摘	Franco EL Villa LL Sobrinho JP	1999	J Infect Dis1999，180，5：	1
12	Human papillomavirus and cervical cancer:Burden of illness and basis for prevention显示文摘	Trottier H Franco EL	2006	Am J Manag Care2006，12，17：	1
13	The epidemology of genital human papillomarirus infection显示文摘	Troltier H Franco EL		0，，1：	1
14	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus type 16 and 18 in young women: a randomized controlled trial 显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
15	P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer:Effect of inter-laboratory variation显示文摘	Makni H Franco EL Kaiano J	2000	Int J Cancer2000，87，：	1
16	The epidemiology of cervical cancer显示文摘	Franco EL Schlecht NF Saslow D	2003	Cancer J2003，9，5：	1
17	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
18	Efficacy of a bivalent L1 virusqike particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial 显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1
19	Efficacy of abivalent L1 virus- like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial 显示文摘	Haper DM Franco EL Wheeler G	2004	Lancet2004，364，9447：	1
20	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with hu- man papillomavirus types 16 and 18 in young women: a random- ised controlled trial显示文摘	Harper DM Franco EL Wheeler C	2004	Lancet2004，364，9447：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示